title: Combining two orally active iron chelators for thalassemia.
authors.forename: Vasilios
authors.initials: V
authors.lastname: Berdoukas
authors.forename: Susan
authors.initials: S
authors.lastname: Carson
authors.forename: Anne
authors.initials: A
authors.lastname: Nord
authors.forename: Ani
authors.initials: A
authors.lastname: Dongelyan
authors.forename: Stephen
authors.initials: S
authors.lastname: Gavin
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Hofstra
authors.forename: John C
authors.initials: JC
authors.lastname: Wood
authors.forename: Thomas
authors.initials: T
authors.lastname: Coates
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000077543:Deferiprone; D003676:Deferoxamine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007502:Iron Chelating Agents / Q000008:administration & dosage / Q000627:therapeutic use; D011728:Pyridones / Q000008:administration & dosage / Q000627:therapeutic use*; D017262:Siderophores / Q000008:administration & dosage / Q000627:therapeutic use*; D013789:Thalassemia / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D007502:Iron Chelating Agents; D011728:Pyridones; D017262:Siderophores; D000077543:Deferiprone; D003676:Deferoxamine